blog-icon

Clinical research blog

Explore our blog for insights into the big questions in precision medicine and clinical research.

Podcast recap: Huma Qamar on pioneering gene therapy for retinal disease

In a recent episode of The Genetics Podcast, Dr. Huma Qamar, Chief Medical Officer at Ocugen, shares her extraordinary journey from a small town in Pakistan to ...
Continue reading

Podcast recap: Frank Gentile on harnessing autophagy to treat neurodegenerative diseases

In a recent episode of The Genetics Podcast, we talked to Frank Gentile, Chief Executive Officer of Casma Therapeutics, to explore how autophagy could be a valu...
Continue reading

Smarter trials with AI: For engineers and data teams

Technological advances and biomedical breakthroughs have triggered a paradigm shift in precision medicine. Clinical research is currently at a turning point at ...
Continue reading

AI at the FDA: Impact on drug development

In May and June of 2025, the Food and Drug Administration (FDA) announced a series of developments related to the use of artificial intelligence (AI) across its...
Continue reading

Personalized medicine for DMD: Genetics to treatment

Duchenne muscular dystrophy (DMD) is an inherited disorder that is characterized by progressive muscle degeneration, leading to loss of function and premature d...
Continue reading

Podcast recap: Andres Moreno-Estrada on mapping Latin America's genetic legacy and its future

On a recent episode of The Genetics Podcast, Patrick was joined by Andres Moreno-Estrada, population geneticist and head of the Human Evolutionary Genomics Lab ...
Continue reading

Insights from the GBA1 conference: A call for precision and inclusion

We recently attended the GBA1 conference in Montreal, which brought together researchers, clinicians, biotech leaders, and patient advocates to discuss cutting-...
Continue reading

How precision medicine is advancing myasthenia gravis treatment

Myasthenia gravis (MG) is a chronic neuromuscular disorder (NMD) that is characterized by muscle fatigue and weakness. It is considered a rare disease, affectin...
Continue reading

Podcast recap: Frank Gleeson on targeting muscle regeneration to tackle Duchenne muscular dystrophy

On a recent episode of The Genetics Podcast, Patrick spoke with Frank Gleeson, co-founder and CEO of Satellos Bioscience, a Canadian biotech pioneering a regene...
Continue reading

Q2 2025 product update: New features for seamless trial execution

At Sano Genetics, our mission is to make clinical research in precision medicine faster, more inclusive, and more efficient. In our Q2 2025 product webinar, we ...
Continue reading